201 related articles for article (PubMed ID: 947865)
21. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
22. [Special problems of early detection of malignant tumors of the genito-urinary system (author's transl)].
Mebel M; Vogler H
Arch Geschwulstforsch; 1981; 51(8):679-84. PubMed ID: 6176207
[No Abstract] [Full Text] [Related]
23. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
24. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors.
Mostofi FK; Sesterhenn I
Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
[TBL] [Abstract][Full Text] [Related]
26. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
[No Abstract] [Full Text] [Related]
27. Tumor and serum CEA content in gynecologic neoplasms.
Kula J; Richter R; Gawlikowski W; Harłozińska A
Neoplasma; 1984; 31(1):89-93. PubMed ID: 6322027
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of CEA in urine of patients with bladder carcinoma.
Persijn JP; Korsten CB; Renaud J
Z Klin Chem Klin Biochem; 1974 May; 12(5):232. PubMed ID: 4440123
[No Abstract] [Full Text] [Related]
29. [CEA determination in urogenital tract neoplasms].
Hering H; Weidner W; Hering F
Med Lab (Stuttg); 1976 Sep; 29(9):193-8. PubMed ID: 979885
[No Abstract] [Full Text] [Related]
30. Immunobiology of genitourinary tumors.
Lange PH; Hakala TR; Fraley EE
Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
[No Abstract] [Full Text] [Related]
31. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
33. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
Yang SC
Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
[TBL] [Abstract][Full Text] [Related]
34. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
Neville AM; Nery R; Hall RR; Turberville C; Laurence DJ
Br J Cancer Suppl; 1973 Aug; 1():198-207. PubMed ID: 4216361
[No Abstract] [Full Text] [Related]
35. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
37. [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
Inai H; Shimazui T; Yamamoto T; Yamauchi A; Uchida K; Takeshima H; Akaza H
Hinyokika Kiyo; 2001 Aug; 47(8):583-6. PubMed ID: 11579601
[TBL] [Abstract][Full Text] [Related]
38. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
Moreno Sierra J; Ortega MD; Blanco Jimenez E; Maestro de las Casas ML; Delgado Marti JA; Hermida Gutierrez J; Salinas Casado J; Esteban Fuertes M; Resel Estévez L
Arch Esp Urol; 1994; 47(1):39-42. PubMed ID: 8192496
[TBL] [Abstract][Full Text] [Related]
39. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
[TBL] [Abstract][Full Text] [Related]
40. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]